FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Vet Pharmacol Ther / Pharmacokinetics of diphenhydramine following single-dose in...
Journal of veterinary pharmacology and therapeutics2021; 45(2); 188-195; doi: 10.1111/jvp.13041

Pharmacokinetics of diphenhydramine following single-dose intravenous and oral administration in non-fasted adult horses.

Abstract: Diphenhydramine is an H1 receptor antagonist used to control urticaria and other allergic signs caused by type I hypersensitivity reactions in horses (Equus caballus). Limited studies have been conducted on pharmacokinetics of this drug in horses, with no studies involving oral formulations. Our study investigated pharmacokinetics of an oral diphenhydramine formulation compared to intravenous administration in non-fasted adult horses. Six healthy horses underwent a single administration of three different doses of diphenhydramine (1 mg/kg intravenously, 1 mg/kg intragastrically, and 5 mg/kg intragastrically) with a two-week washout period between doses. Bioavailability of intragastric diphenhydramine was less than one percent and six percent for 1 mg/kg and 5 mg/kg intragastric doses, respectively. This poor bioavailability is similar to what is reported in dogs. Two of six horses experienced transient side effects after intravenous diphenhydramine administration, emphasizing the need for determining therapeutic plasma levels in efforts to determine the lowest effective dose minimizing risk of adverse effects. The main conclusion of our study was that oral diphenhydramine at doses up to 5 mg/kg are unlikely to achieve therapeutic plasma levels in adult horses.
© 2021 John Wiley & Sons Ltd.
Get Full Text
Publication Date: 2021-12-17 PubMed ID: 34921427DOI: 10.1111/jvp.13041Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study focuses on the effectiveness of diphenhydramine, an antihistamine medication, when it’s administered intravenously and orally to adult horses. The results suggest that oral administration of the drug is much less effective, pointing to a need for further studies to establish the most efficient dosage and method of administering the drug that minimizes side effects.

Research Methodology

  • The study involved six healthy adult horses. These horses were not fasted before the administration of diphenhydramine.
  • Three different doses of diphenhydramine were administered: 1 mg/kg intravenously, 1 mg/kg intragastrically (through the stomach), and 5 mg/kg intragastrically.
  • A period of two weeks was given between each dose for a thorough washout, ensuring that any residual effects from the previous doses were eliminated.

Findings

  • The oral bioavailability of diphenhydramine at each dose was found to be less than one percent and six percent for the 1 mg/kg and 5 mg/kg intragastric doses, respectively, suggesting that the oral route is inefficient for absorption of diphenhydramine in horses.
  • The low bioavailability observed in this study is similar to that reported in earlier studies in dogs.
  • Two of the six horses subjected to intravenous administration showed transient side effects indicating that careful attention needs to be paid to dosing to minimize adverse reactions.

Conclusion

  • The significant finding of the research was that oral dosing of diphenhydramine at doses up to 5 mg/kg is unlikely to result in therapeutic plasma levels in adult horses. This implies that alternative routes of administration or higher doses may be needed to achieve therapeutic effects.
  • There is a need for further research to establish the most effective dosage and mode of administration for diphenhydramine in adult horses while minimizing side effects.

Cite This Article

APA
Redmond JS, Stang BV, Schlipf JW, Christensen JM. (2021). Pharmacokinetics of diphenhydramine following single-dose intravenous and oral administration in non-fasted adult horses. J Vet Pharmacol Ther, 45(2), 188-195. https://doi.org/10.1111/jvp.13041

Publication

Journal of veterinary pharmacology and therapeutics
ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 45
Issue: 2
Pages: 188-195

Researcher Affiliations

Redmond, Jeremy S
  • Department of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA.
Stang, Bernadette V
  • Department of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA.
Schlipf, John W
  • Department of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA.
Christensen, John M
  • College of Pharmacy, Oregon State University, Corvallis, Oregon, USA.

MeSH Terms

  • Administration, Intravenous / veterinary
  • Administration, Oral
  • Animals
  • Biological Availability
  • Cross-Over Studies
  • Diphenhydramine
  • Dogs
  • Histamine H1 Antagonists
  • Horses

Grant Funding

  • Oregon State University

References

This article includes 40 references
  1. Albert KS, Hallmark MR, Sakmar E, Weidler DJ, Wagner JG. Pharmacokinetics of diphenhydramine in man. Journal of Pharmacokinetics and Biopharmaceutics 3, 159-170.
    doi: 10.1007/bf01067905google scholar: lookup
  2. Bailey SR. Corticosteroid-Associated Laminitis. The Veterinary Clinics of North America. Equine Practice 26, 277-285.
    doi: 10.1016/j.cveq.2010.04.001google scholar: lookup
  3. Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL. Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clinical Pharmacology and Therapeutics 23, 375-382.
    doi: 10.1002/cpt1978234375google scholar: lookup
  4. Drach JC, Howell JP, Borondy PE, Glazko AJ. Species Differences in the Metabolism of Diphenhydramine (Benadryl). Proceedings of the Society for Experimental Biology and Medicine 135, 849-853.
    doi: 10.3181/00379727-135-35157google scholar: lookup
  5. Duijkeren EV, Kessels B, Oldruiten-borgh-oosterbaan MMS, Breukink HJ, Vulto AG, Miert A. In vitro and in vivo binding of trimethoprim and sulphachlorpyridazine to equine food and digesta and their stability in caecal contents. Journal of Veterinary Pharmacology and Therapeutics 19, 281-287.
    doi: 10.1111/j.1365-2885.1996.tb00050.xgoogle scholar: lookup
  6. Ehling S, Bäumer W, Papich MG. Diphenhydramine pharmacokinetics after oral and intravenous administration of diphenhydramine and oral administration of dimenhydrinate to healthy dogs, and pharmacodynamic effect on histamine-induced wheal formation: A pilot study. Veterinary Dermatology 30, 91-e24.
    doi: 10.1111/vde.12727google scholar: lookup
  7. Furr M, Kennedy T. Effects of coadministration of corn oil and ponazuril on serum and cerebrospinal fluid concentrations of ponazuril in horses. Journal of Veterinary Internal Medicine 34, 1321-1324.
    doi: 10.1111/jvim.15765google scholar: lookup
  8. Furr MO, Murray MJ. Treatment of gastric ulcers in horses with histamine type 2 receptor antagonists. Equine Veterinary Journal 21, 77-79.
    doi: 10.1111/j.2042-3306.1989.tb05661.xgoogle scholar: lookup
  9. Glazko AJ, Dill WA, Young RM, Smith TC, Ogilvie RI. Metabolic disposition of diphenhydramine. Clinical Pharmacology and Therapeutics 16, 1066-1076.
    doi: 10.1002/cpt19741661066google scholar: lookup
  10. Hinden S, Klukowska-Rötzler J, Janda J, Marti EI, Gerber V, Roosje PJ. Characterization of the inflammatory infiltrate and cytokine expression in the skin of horses with recurrent urticaria. Veterinary Dermatology 23, 503-e99.
    doi: 10.1111/j.1365-3164.2012.01117.xgoogle scholar: lookup
  11. Hospira. DiphenhydrAMINE [package insert]. .
  12. Johnson J. BENADRYL- diphenhydramine hydrochloride tablet, film coated [package insert]. .
  13. Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clinical and Experimental Allergy 39, 777-787.
    doi: 10.1111/j.1365-2222.2009.03256.xgoogle scholar: lookup
  14. Knych HK, Stanley SD, Arthur RM, McKemie DS. Elimination of cetirizine following administration of multiple doses to exercised thoroughbred horses. Journal of Veterinary Pharmacology and Therapeutics 39, 522-524.
    doi: 10.1111/jvp.12318google scholar: lookup
  15. Knych HK, Weiner D, Steinmetz S, Flynn K, McKemie DS. Pharmacokinetics of hydroxyzine and cetirizine following oral administration of hydroxyzine to exercised Thoroughbred horses. Journal of Veterinary Pharmacology and Therapeutics 42, 617-623.
    doi: 10.1111/jvp.12808google scholar: lookup
  16. Kohn CW, Muir WW III. Selected aspects of the clinical pharmacology of visceral analgesics and gut motility modifying drugs in the horse. Journal of Veterinary Internal Medicine 2, 85-91.
    doi: 10.1111/j.1939-1676.1988.tb02799.xgoogle scholar: lookup
  17. Koyanagi T, Yamaura Y, Yano K, Kim S, Yamazaki H. Age-related pharmacokinetic changes of acetaminophen, antipyrine, diazepam, diphenhydramine, and ofloxacin in male cynomolgus monkeys and beagle dogs. Xenobiotica 44, 893-901.
    doi: 10.3109/00498254.2014.903532google scholar: lookup
  18. Krenzelok EP, Anderson GM, Mirick M. Massive diphenhydramine overdose resulting in death. Annals of Emergency Medicine 11, 212-213.
    doi: 10.1016/s0196-0644(82)80501-5google scholar: lookup
  19. Kubo N, Shirakawa O, Kuno T, Tanaka C. Antimuscarinic effects of antihistamines: Quantitative evaluation by receptor-binding assay|elsevier enhanced reader. Japanese Journal of Pharmacology 43, 277-282.
    doi: 10.1016/s0021-5198(19)43508-7google scholar: lookup
  20. Lagutchik MS, Hackett TB, Carter LJ, Wagner AE, Wingfield WE. Diphenhydramine intoxication in a dog. Journal of Veterinary Emergency and Critical Care 7, 89-93.
    doi: 10.1111/j.1476-4431.1997.tb00048.xgoogle scholar: lookup
  21. Leclere M. Corticosteroids and Immune Suppressive Therapies in Horses. The Veterinary Clinics of North America. Equine Practice 33, 17-27.
    doi: 10.1016/j.cveq.2016.11.008google scholar: lookup
  22. Leung DYM. Pathogenesis of atopic dermatitis. The Journal of Allergy and Clinical Immunology 104, S99-S108.
    doi: 10.1016/s0091-6749(99)70051-5google scholar: lookup
  23. Leurs R, Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clinical and Experimental Allergy 32, 489-498.
    doi: 10.1046/j.0954-7894.2002.01314.xgoogle scholar: lookup
  24. Mc KENZIE EC, Garrett RL, Payton ME, Riehl JH, Firshman AM, Valberg SJ. Effect of feed restriction on plasma dantrolene concentrations in horses. Equine Veterinary Journal 42, 613-617.
    doi: 10.1111/j.2042-3306.2010.00262.xgoogle scholar: lookup
  25. Olivry T, Bizikova P. A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update. Veterinary Dermatology 24, 97-e26.
    doi: 10.1111/j.1365-3164.2012.01088.xgoogle scholar: lookup
  26. Olsén L, Bondesson U, Broström H, Olsson U, Mazogi B, Sundqvist M, Tjälve H, Ingvast-Larsson C. Pharmacokinetics and effects of cetirizine in horses with insect bite hypersensitivity. The Veterinary Journal 187, 347-351.
    doi: 10.1016/j.tvjl.2009.12.030google scholar: lookup
  27. Olsén L, Bondesson U, Broström H, Tjälve H, Ingvast-Larsson C. Cetirizine in horses: Pharmacokinetics and pharmacodynamics following repeated oral administration. The Veterinary Journal 177, 242-249.
    doi: 10.1016/j.tvjl.2007.03.026google scholar: lookup
  28. Olsén L, Ingvast-larsson C, Bondesson U, Broström H, Tjälve H, Larsson P. Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment. Journal of Veterinary Pharmacology and Therapeutics 30, 194-200.
    doi: 10.1111/j.1365-2885.2007.00850.xgoogle scholar: lookup
  29. Paton DM, Webster DR. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). Clinical Pharmacokinetics 10, 477-497.
    doi: 10.2165/00003088-198510060-00002google scholar: lookup
  30. Rufenacht S, Marti E, Von tscharner C, Doherr MG, Forster U, Welle M, Roosje PJ. Immunoglobulin E-bearing cells and mast cells in skin biopsies of horses with urticaria. Veterinary Dermatology 16, 94-101.
    doi: 10.1111/j.1365-3164.2005.00440.xgoogle scholar: lookup
  31. Sanchez A, Valverde A, Sinclair M, Mosley C, Singh A, Mutsaers AJ, Hanna B, Gu Y, Johnson R. The pharmacokinetics of DPH after the administration of a single intravenous or intramuscular dose in healthy dogs. Journal of Veterinary Pharmacology and Therapeutics 39, 452-459.
    doi: 10.1111/jvp.12293google scholar: lookup
  32. Sanchez A, Valverde A, Sinclair M, Mosley C, Singh A, Mutsaers AJ, Hanna B, Johnson R, Gu YU, Beaudoin-Kimble M. Antihistaminic and cardiorespiratory effects of diphenhydramine hydrochloride in anesthetized dogs undergoing excision of mast cell tumors. Journal of the American Veterinary Medical Association 251, 804-813.
    doi: 10.2460/javma.251.7.804google scholar: lookup
  33. Scott DW, Miller WH Jr. Equine Dermatology, 2nd ed.. .
  34. Stepnik CT, Outerbridge CA, White SD, Kass PH. Equine atopic skin disease and response to allergen-specific immunotherapy: A retrospective study at the University of California-Davis (1991-2008). Veterinary Dermatology 23, 29-e7.
    doi: 10.1111/j.1365-3164.2011.01001.xgoogle scholar: lookup
  35. Thakur AC, Aslam AK, Aslam AF, Vasavada BC, Sacchi TJ, Khan IA. QT interval prolongation in diphenhydramine toxicity. International Journal of Cardiology 98, 341-343.
    doi: 10.1016/j.ijcard.2003.10.051google scholar: lookup
  36. Wang C, Fan G, Lin M, Chen YI, Zhao W, Wu Y. Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of d-amphetamine and diphenhydramine in beagle dog plasma and its application to a pharmacokinetic study. Journal of Chromatography B 854, 48-56.
    doi: 10.1016/j.jchromb.2007.03.038google scholar: lookup
  37. Wasfi IA, Abdel Hadi AA, Elghazali M. Comparative pharmacokinetics of diphenhydramine in camels and horses after intravenous administration. Veterinary Research Communications 27, 463-473.
    doi: 10.1023/a:1025789607863google scholar: lookup
  38. Wittenberg-Voges L, Kästner SBR, Raekallio M, Vainio OM, Rohn K, Hopster K. Effect of dexmedetomidine and xylazine followed by MK-467 on gastrointestinal microperfusion in anaesthetized horses. Veterinary Anaesthesia and Analgesia 45, 165-174.
    doi: 10.1016/j.vaa.2017.08.010google scholar: lookup
  39. Yanai K, Okamura N, Tagawa M, Itoh M, Watanabe T. New findings in pharmacological effects induced by antihistamines: from PET studies to knock-out mice. Clinical and Experimental Allergy 29, 29-36.
    doi: 10.1046/j.1365-2222.1999.00008.x-i1google scholar: lookup
  40. Yanai K, Ryu JH, Watanabe T, Iwata R, Ido T, Sawai Y, Ito K, Itoh M. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography. British Journal of Pharmacology 116, 1649-1655.
    doi: 10.1111/j.1476-5381.1995.tb16386.xgoogle scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.